Pharmaceuticals, Biotechnology and Life Sciences
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Cell Microsystems, a provider of innovative tools for single cell research, announced today it has received…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Cell Microsystems, a provider of innovative tools for single cell research, announced today it has received…
Fulcrum plans to launch a Phase 2b clinical trial in FSHD in mid-2019 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Fulcrum Therapeutics, a biotechnology company…
Fulcrum plans to launch a Phase 2b clinical trial in FSHD in mid-2019 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Fulcrum Therapeutics, a biotechnology company…
Sales of $514 million declined 3% as reported and were flat in constant currency Recurring revenue growth offset by declines…
Sales of $514 million declined 3% as reported and were flat in constant currency Recurring revenue growth offset by declines…
DUBLIN–(BUSINESS WIRE)–The “Global Central Nervous System Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering.…
Compelling additional preclinical data further support therapeutic potential of gene therapy products to treat Wilson disease (WD) and Progressive Familial…
Trial will evaluate the efficacy of AVID100 in TNBC patients with EGFR-overexpression 20% of TNBC patients highly overexpress EGFR; there…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…